Providers can sign up for early access here: To view or add a comment, sign in For anyone interested in the status of the PCAC meeting (FDA and Peptides), here is a good (and not too long!) update
Kylo Peptides is a chemical research supplier not a compounding pharmacy or outsourcing facility under sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act and supplies no compounded preparations
If you don't you should check it out
These schedules are meant to replenish B12 first, then maintain it over time
Label all solutions immediately after preparation
Stop and Seek Help If Severe allergic reaction (rash, swelling, difficulty breathing) Persistent severe nausea or vomiting not improving with dose reduction Signs of pancreatitis (severe abdominal pain radiating to back) Planned pregnancy or positive pregnancy test Inability to maintain adequate nutrition despite dose adjustments Any concerning symptoms your healthcare provider advises stopping for Always consult your healthcare provider before stopping or modifying your dose